The government of Malaysia is subsidizing the cost of medicines by about300 million ringgit ($78.9 million) annually, according to Deputy Health Minister Suleiman Mohamed, who added at a press conference in Kuala Lumpur that this has enabled the nation's low-income groups to buy prescription drugs and medical supplies at low prices.
Dr Suleiman said the prices of prescribed drugs on the Malaysian market are monitored by the Domestic Trade and Consumer Affairs Ministry, reports the Marketletter's local correspondent, who adds that the Minister's comments followed a report that international drug companies planned to increase the prices of imported drugs some 10%-20%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze